INS and Alzheimer disease: Due to the close association between T2DM and AD, it is possible that drugs developed to treat T2DM, which targets insulin signaling, may be applied to prevent or suspend neuronal apoptosis in AD brain and lead to less cognitive impairment in AD patients.